Anti-human LAG-3 monoclonal antibody and use thereof
US11685778B2 · kind B2 · utility
0Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2019 |
| Grant date | Jun 27, 2023 |
| Priority date | — |
| Expiry date | Nov 29, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed in the present invention are an antibody targeting LAG-3, a preparation method therefor and the use thereof. In particular, disclosed in the present invention is a novel monoclonal antibody targeting LAG-3. Also disclosed in the present invention is a method for the preparation of the monoclonal antibody. The monoclonal antibody of the present invention is capable of binding LAG-3 antigens with high specificity, and has very high affinity and significant activities such as anti-tumor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.